insulin glargine and lixisenatide
1 NDC across 1 manufacturer|0 Generic,1 Brand
Insulin glargine and lixisenatide is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $57.10 to $57.10 per unit. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$57.10 – $57.10
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Frequently Asked Questions
How many Insulin glargine and lixisenatide products are on the market?
The Insulin glargine and lixisenatide drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Insulin glargine and lixisenatide?
NADAC reference prices for Insulin glargine and lixisenatide range from $57.0959 to $57.0959 per unit.
Which manufacturers make Insulin glargine and lixisenatide?
1 manufacturer lists Insulin glargine and lixisenatide in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (1).
How has the price of Insulin glargine and lixisenatide changed recently?
Over the past 7 days, 2 Insulin glargine and lixisenatide NDCs rose and 0 fell, with a market-wide average change of +0.0%.
Manufacturer Breakdown
1 manufacturer producing insulin glargine and lixisenatide
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SOLIQUA 100 UNIT-33 MCG/ML PEN | $57.0959 per ML | +0.02% |